Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster-Reference-Cited by-同舟云学术

Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster

Published:2020-05-18 Issue:7 Volume:47 Page:683-688
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Shoji Naoko¹,Tanese Keiji¹^ORCID,Sasaki Ayano¹,Horiuchi Taishi¹,Utsuno Yuji¹,Fukuda Koichi¹,Hoshino Yukiko¹,Noda Shinichi¹,Minami Hirofumi¹,Asakura Wataru¹,

Affiliation:

1. Office of New Drug IV, Pharmaceuticals and Medical Device Agency Tokyo Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15393

Reference11 articles.

1. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2

2. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study

3. Characterization of virus strains resistant to the herpes virus helicase–primase inhibitor ASP2151 (Amenamevir)

4. Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Amenamevir, a Helicase-Primase Inhibitor for the Treatment of Acyclovir-Resistant Herpes Simplex Virus 1 Keratitis;Cornea;2024-04-25

2. The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review;Journal of Clinical Medicine;2024-03-16

3. Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients;Viruses;2023-07-21

4. Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles;International Journal of Molecular Sciences;2023-03-12

5. Amenamevir by Ugi-4CR;Green Chemistry;2023